PHR · Phreesia, Inc.
$9.80
-0.21 (-2.10%)
At close · Jul 23
Market Cap
$605.76M
Shares
61.81M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$480.59M
+14.5%
FY2026
Net Income
$2.31M
+103.9%
FY2026
Operating Margin
-1.38%
+12.5pp
FY2026
Diluted EPS
$0.04
+103.9%
FY2026
Operating Cash Flow
$78.81M
+143.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2027 (G) | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $510M – $520M | $495.59M | $480.59MG | $419.81M | $356.3M | $280.91M | $213.23M | $148.68M | $124.78M | $99.89M | $79.83M | |
| — | — | — | — | $2.21M | $1.06M | -$1.08M | -$1.57M | -$2.45M | -$3.5M | -$3.64M | |
| — | $117.98M | $121.48M | $117.36M | $112.35M | $91.24M | $52.27M | $22.62M | $18.62M | $14.35M | $11.38M | |
| — | $98.41M | $100.24M | $121.13M | $147.01M | $151.26M | $106.42M | $42.97M | $32.36M | $26.37M | $24.76M | |
| — | $81.86M | $79.9M | $76.6M | $79.93M | $80.38M | $68.67M | $40.46M | $30.46M | $20.08M | $18.84M | |
| — | — | $5.08M | $3.48M | $2.38M | $1.37M | $653K | $254K | $238K | $33K | $0 | |
| — | $34.53M | $31.45M | $27.89M | $29.49M | $25.3M | $21.3M | $15.91M | $13.92M | $11.59M | $9.64M | |
| — | $492.17M | $487.2M | $477.91M | $492.78M | $457.46M | $330.05M | $174.35M | $140.08M | $109.38M | $94.39M | |
| — | $3.42M | -$6.61M | -$58.1M | -$136.48M | -$176.55M | -$116.82M | -$25.67M | -$15.3M | -$9.49M | -$14.55M | |
| — | — | -1.38% | -13.84% | -38.3% | -62.85% | -54.78% | -17.27% | -12.26% | -9.5% | -18.23% | |
| — | $37.95M | $24.84M | -$30.21M | -$106.99M | -$151.25M | -$95.52M | -$9.76M | -$1.37M | $2.1M | -$4.91M | |
| — | $8.82M | $6.95M | $2.35M | $1.85M | $1.41M | $1.16M | $1.7M | $3.04M | $3.51M | — | |
| — | $2.27M | $2.17M | $2.68M | $4.07M | $2.48M | — | — | — | — | — | |
| — | -$4.46M | -$2.33M | $2.29M | $1.14M | $889K | -$1.16M | -$1.57M | -$6.78M | -$5.57M | -$3.64M | |
| — | -$1.04M | -$8.94M | -$55.81M | -$135.34M | -$175.66M | -$117.98M | -$27.24M | -$22.07M | -$15.06M | -$18.19M | |
| — | -$10.22M | -$11.25M | $2.72M | $1.54M | $483K | $182K | $49K | -$1.78M | $0 | $0 | |
| — | $9.18M | $2.31M | -$58.53M | -$136.89M | -$176.15M | -$118.16M | -$27.29M | -$20.29M | -$15.06M | -$18.19M | |
| — | — | 0.48% | -13.94% | -38.42% | -62.71% | -55.41% | -18.36% | -16.26% | -15.08% | -22.79% | |
| — | — | — | — | — | — | -$118.16M | -$27.29M | -$91.42M | -$45.26M | -$38.17M | |
| — | $8.23M | $1.98M | -$58.58M | -$136.89M | -$176.15M | — | — | — | — | — | |
| USD/shares | — | — | $0.04 | -$1.02 | -$2.51 | -$3.36 | -$2.37 | -$0.69 | -$4.50 | — | — |
| USD/shares | — | — | $0.04 | -$1.02 | -$2.51 | -$3.36 | -$2.37 | -$0.69 | -$4.50 | — | — |
| shares | — | — | 59.74M | 57.59M | 54.56M | 52.44M | 49.89M | 39.52M | 20.3M | 1.84M | 1.54M |
| shares | — | — | 61.49M | 57.59M | 54.56M | 52.44M | 49.89M | 39.52M | 20.3M | 1.84M | 1.54M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Health Information Services median 1.32×
EV/EBIT
—
Health Information Services median 25.02×
P/E (TTM)
61.25×
Health Information Services median 31.84×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Technology Solutions Segment | $480,591,000 | $419,813,000 | $356,299,000 | $280,910,000 |
By Product & Service (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Subscription and Services | $219,461,000 | $196,510,000 | $165,436,000 | $128,975,000 | $95,514,000 | $69,042,000 | $56,357,000 | $43,928,000 |
| Network Solutions | $139,671,000 | $121,563,000 | $96,253,000 | $73,567,000 | $52,518,000 | $29,735,000 | — | — |
| Payment Solutions | $121,459,000 | $101,740,000 | $94,610,000 | — | — | — | — | — |
| Life Sciences | — | — | — | — | — | — | $21,927,000 | $19,080,000 |
| Payment Processing Fees | — | — | — | $78,368,000 | $65,201,000 | $49,900,000 | $46,500,000 | $36,881,000 |
Key facts
CIK
1412408
CUSIP
71944F106
13F (30d)
24 filings
24 filers
Visit website
Investor relations